Инфантильный нефротический синдром при галактосиалидозе
Аннотация
Об авторах
М. Е. АксеноваРоссия
Т. А. Никишина
Россия
М. С. Игнатова
Россия
А. Н. Семячкина
Россия
Н. Ф. Назарова
Россия
И. В. Цветкова
Россия
Список литературы
1. D’Azzo A., Hoogeveen A., Reuser A.J. et al. Molecular defect in combined beta-galactosidase and neurominidase deficiency in man. Proc Nat Acad Sci 1982; 79: 4535-4539.
2. De Geest N., Bonten E., Mann L. et al. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 2002; 11 (12): 1455-1464.
3. Goldberg M.F., Cotlier E., Fichenscher L.G. et al. Macular cherry-red spot, corneal clouding, and beta-galactosidase deficiency: clinical, biochemical, and electron microscopic study of a new autosomal recessive storage disease. Arch Intern Med 1971; 128: 387-398.
4. Habib R. Nephrotic syndrome in the 1st year of life. Pediatr Nephrol 1993; 7: 347-353.
5. Hoogeven A., d’Azzo A., Brossmer R., Galjaard H. Correction of combined beta-galactosidase/neirominidase deficiency in human fibroblasts. Biochem Biophys Res Commun 1981; 103: 292-299.
6. Itoh K., Minaru N., Ohama K. et al. Fetal diagnosis of galactosialidosis (protective protein/cathepsin A deficiency). Clin Chim Acta 1997; 266 (2): 75-82.
7. Kleijer W.J., Geilen G.C., Janse H.C. et al. Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families. Pediatr Res 1996; 39 (6): 1067-1071.
8. Le Sec G., Stanescu R., Lyon G. A new type of sialidosis with kidney disease: nephrosialidosis. Arch Fr Pediatr 1978; 35 (8): 830-844.
9. Lukong K.E., Landry K., Elsliger M. et al. Mutation in sialidosis impair sialidase binding to the lisosomal multienzyme complex. J Biol Chem 2001; 20: 17 286-17 290.
10. Mauch T., Vernier R., Burke B., Nevins T. Nephrotic syndrome in the first year of life. Pediatric Nephrology, 2nd edition, edited by Holliday M.A., Barrat T.M., Avner E.D. Baltimor: Williams&Wilkins, 1994: 788-803.
11. Palmeri S., Hoogeveen A.T., Verheijen F.W., Galjaard H. Galactosialidosis: molecular heterogeneity among distinct clinical phenotypes. Am J Hum Genet 1986; 38: 137-148.
12. Patel M.S., Cllahan J.W., Zhang S. et al. Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up. Am J Med Genet 1999; 85 (1): 38-47.
13. Rottier R.J., Hahn C.N., Mann L.W. et al. Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA. Hum Mol Genet 1998; 7 (11): 1787-1794.
14. Tanako T., Shimmoto M., Fukuhara Y. et al. Galactosialidosis: clinical and molecular analysis of 19 japanese patients. Brain Dysfunction 1991; 4: 271-280.
15. Toyaooka K., Fujimura H., Yoshikawa H. et al. Nephrosialidosis: ultrastructural and lectin histochemical study. Acta Neuropathol 1993; 86 (2): 198-205.
16. Vinogradova M.V., Michaud L., Mezentsev A.V. et al. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation. Biochem J 1998; 330 (Pt2): 641-650.
17. Wiegant J., Galjart N.J., Rapp A.K., D’Azzo A. The gene encoding human protective protein (PPBG) is on chromosome 20. Genomics 1991; 10: 345-349.
18. Zhou X.-Y., van der Spoel A., Rottier R., Hale G. Molecular and biochemical analysis of protective protein/catepsin A mutations: correlation with clinical severity in galactosialidosis. Hum Molec Genet 1996; 5: 1977-1987.
Рецензия
Для цитирования:
Аксенова М.Е., Никишина Т.А., Игнатова М.С., Семячкина А.Н., Назарова Н.Ф., Цветкова И.В. Инфантильный нефротический синдром при галактосиалидозе. Нефрология и диализ. 2005;7(1):73-76.
For citation:
Aksenova M.E., Nikishina T.A., Ignatova M.S., Semiachkina A.N., Nazarova N.F., Zvetkova I.V. Infantile nephrotic syndrome in an infant with galactosialidosis. Nephrology and Dialysis. 2005;7(1):73-76. (In Russ.)